Publication:
Benefit from adjuvant anthracyclines according to hormone receptor status

Simple item page
dc.contributor.authorDANE, FAYSAL
dc.contributor.authorYUMUK, PERRAN FULDEN
dc.contributor.authorsBasaran, G. Atalay; Cabuk, D.; Teomete, M.; Gulluoglu, B.; Kaya, H.; Dane, F.; Yumuk, P. F.; Turhal, N. S.
dc.date.accessioned2022-03-10T17:49:23Z
dc.date.accessioned2026-01-11T13:22:38Z
dc.date.available2022-03-10T17:49:23Z
dc.date.issued2008
dc.identifier.doi10.1200/jco.2008.26.15_suppl.11513
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/221127
dc.identifier.wosWOS:000208457400028
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleBenefit from adjuvant anthracyclines according to hormone receptor status
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume26

Files

Collections

Araştırma Çıktıları